The blocking activity of birch pollen-specific immunotherapy-induced IgG4 is not qualitatively superior to that of other IgG subclasses
- 2 June 2004
- journal article
- Published by Elsevier in Molecular Immunology
- Vol. 41 (5) , 471-478
- https://doi.org/10.1016/j.molimm.2004.04.018
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- IL‐10 and TGF‐β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapyEuropean Journal of Immunology, 2003
- Normal human immunoglobulin G4 is bispecific: it has two different antigen‐combining sitesImmunology, 1999
- Allergen Immunotherapy: Therapeutic Vaccines for Allergic DiseasesAnnals of Allergy, Asthma & Immunology, 1998
- Serial studies on the functional affinity and heterogeneity of antibodies of different IgG subclasses to phospholipase A produced in response to bee-venom immunotherapyJournal of Allergy and Clinical Immunology, 1989
- Blocking activity of mite-specific IgG antibodies studied by skin testsAllergy, 1989
- Diagnosis and immunotherapy of mould allergyAllergy, 1988
- Immunotherapy with cat- and dog-dander extracts II. In vivo and in vitro immunologic effects observed in a 1-year double-blind placebo studyJournal of Allergy and Clinical Immunology, 1986
- Effect of immunotherapy on immunoglobulin E and immunoglobulin G antibodies to ragweed antigens: A six-year prospective studyJournal of Allergy and Clinical Immunology, 1982
- Estimation of Affinity and Quantity of Human Antigen-Specific Serum IgG (Blocking Antibodies)Allergy, 1981
- Subclass Typing of IgG Antibodies Formed by Grass Pollen-Allergic Patients during ImmunotherapyInternational Archives of Allergy and Immunology, 1976